TL;DR
This study uncovers the molecular mechanisms behind the cardiotoxicity of thioridazine (THIO), a common antipsychotic. THIO disrupts the function of cardiac ion channels (hERG and L-type calcium channels) by inducing oxidative stress, leading to prolonged cardiac action potentials and potentially dangerous arrhythmias.
What Problem Does This Paper Address?
Thioridazine (THIO) is a widely used antipsychotic medication, but its use is limited by a significant risk of cardiotoxicity, specifically QT interval prolongation. This electrical abnormality can lead to life-threatening ventricular arrhythmias like Torsades de Pointes. While THIO's acute effects on cardiac channels are known, the long-term mechanisms driving this cardiotoxicity, especially concerning chronic drug exposure, remained unclear. This paper aims to elucidate these underlying molecular pathways, focusing on how THIO affects key ion channels involved in cardiac repolarization.
Methods
The researchers employed a multi-pronged approach to investigate THIO's cardiotoxic effects:
- Patch Clamp Electrophysiology: This technique was used to measure the electrical currents flowing through specific ion channels (hERG and L-type calcium channels) in isolated cells. This allowed them to assess how THIO affects channel function and kinetics.
- Western Blotting: This method was used to quantify the protein levels of key molecules, including ion channels (hERG), endoplasmic reticulum (ER) stress markers (ATF6, GRP78, PDI, calnexin, calreticulin), and signaling proteins (CaMKII).
- Co-immunoprecipitation: This technique was used to study the interactions between proteins, specifically examining how THIO affects the association between the hERG channel and its chaperone protein, Hsp70.
- Flow Cytometry and Confocal Microscopy: These techniques were used to measure the production of reactive oxygen species (ROS) within cells, a key indicator of oxidative stress.
- Optical Mapping: This advanced technique allowed for the visualization and measurement of electrical activity (action potential duration) across entire heart preparations, providing a more holistic view of THIO's impact on cardiac repolarization.
- Cell Culture Models: The study utilized several cell models: hERG-HEK293 cells (for hERG channel studies), neonatal rat ventricular myocytes (NRVMs) (for L-type calcium channel and intracellular calcium studies), and human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) (for action potential studies).
Datasets
Not discussed in the paper. The study relies on experimental data generated from cell cultures and animal models.
Key Insights and Ideas
- THIO's Dual Threat: THIO doesn't just block one pathway; it simultaneously impairs the function of two critical cardiac ion channels: it reduces the amount of functional hERG channels and enhances the activity of L-type calcium channels.
- Oxidative Stress as the Culprit: Reactive Oxygen Species (ROS) are identified as the central mediators of THIO's cardiotoxicity. THIO triggers a surge in ROS, which then initiates a cascade of detrimental events.
- ER Stress and hERG Degradation: The increased ROS leads to endoplasmic reticulum (ER) stress. This stress disrupts the proper folding and trafficking of hERG channels, ultimately leading to their increased degradation. The study highlights the disruption of hERG-Hsp70 interactions as a key step in this process.
- CaMKII Activation and Calcium Overload: ROS also activate Ca2+/calmodulin-dependent protein kinase II (CaMKII). Activated CaMKII, in turn, enhances the activity of L-type calcium channels, leading to an overload of intracellular calcium.
- Long-Term vs. Acute Effects: While THIO is known to acutely block hERG channels, this study reveals that chronic exposure leads to a deficiency in hERG channel expression and function, rather than altering channel kinetics.
Key Results
- hERG Channel Dysfunction: THIO treatment significantly reduced mature hERG protein levels and hERG current density in a concentration-dependent manner. This effect was observed after 24-hour incubation.
- ER Stress Activation: THIO treatment led to the upregulation of ER stress markers (cleaved ATF6, GRP78, PDI, calnexin, calreticulin).
- ROS Mediation: ROS production was significantly increased by THIO, and this increase was attenuated by the ROS scavenger N-acetyl cysteine (NAC). NAC also reversed THIO-induced hERG reduction and ER stress.
- hERG Degradation Pathway: THIO disrupted the interaction between hERG and its chaperone Hsp70, leading to increased ubiquitination and degradation of hERG proteins, primarily via lysosomal pathways.
- L-type Calcium Channel Activation: THIO increased L-type calcium current (ICa-L) density and intracellular calcium ([Ca2+]i) in cardiomyocytes. This effect was attenuated by the CaMKII inhibitor KN-93, indicating ROS-mediated CaMKII activation.
- Cardiac Action Potential Prolongation: Optical mapping in mouse hearts and experiments with hiPSC-CMs showed that THIO significantly prolonged action potential duration (APD50 and APD90) and increased the incidence of early afterdepolarizations (EADs).
Limitations and Future Work
- Cell Line vs. In Vivo: While the study uses various cell models and isolated hearts, the full complexity of in vivo drug effects and interactions within a whole organism are not fully captured.
- Therapeutic Window: The study focuses on the mechanisms of cardiotoxicity. Future work could explore whether co-administration of antioxidants with THIO could mitigate cardiotoxicity while preserving therapeutic efficacy, as suggested in the discussion.
- Specific ER Stress Pathways: While ER stress is implicated, further detailed investigation into the specific UPR (Unfolded Protein Response) pathways activated by THIO could provide deeper insights.
- Lysosomal vs. Proteasomal Degradation: While the study differentiates the roles of lysosomes and proteasomes in hERG degradation, further refinement of these pathways could be explored.
The authors suggest that co-application of antioxidants with THIO might be beneficial for patients, potentially enhancing cardiosafety and reducing cardiotoxicity.
Summary updated